For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Synthetic peptide from the N terminal region of human CaMKIV.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Our Abpromise guarantee covers the use of ab75874 in the following tested applications.
ab75874 has not yet been referenced specifically in any publications.